MED-EL is a leading manufacturer of innovative implantable hearing solutions to treat various degrees of hearing loss, including cochlear, middle ear and bone conduction implant systems.
MED-EL’s mission is to “overcome hearing loss as a barrier to communication and quality of life” in children and adults. For nearly 40 years, MED-EL founders Ingeborg and Erwin Hochmair have been pioneering cochlear implant research. The company’s products are the result of focused research and development, and a commitment to fostering close relationships with users as well as clinics and research organizations around the world. Currently, MED-EL is working in close collaboration with more than 30 research institutes worldwide in all aspects of technology and clinical related research. MED-EL’s Headquarters are based in Innsbruck, Austria. With more than 1400 employees, MED-EL is present in more than 100 countries.